REPUBLIC CONSULTING, LLC for AMGEN USA INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Support changes to inter partes review system (S. 1137, PATENT Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER HUNTER BATES | — |
Natural Resources NAT
Monitor legislation to address Puerto Rico debt crisis (H.R. 5278, S. 2328)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER HUNTER BATES | — |
| LAUREN O'BRIEN | — |
Trade (domestic/foreign) TRD
Monitor TPP discussions and express concern regarding drug exclusivity provisions of TPP
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER HUNTER BATES | — |
Taxation/Internal Revenue Code TAX
Monitor tax reform issues, including international reform, corporate integration, and House GOP Tax Reform Task Force blueprint; Monitor discussions regarding Treasury's IRC Section 385 proposed regulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER HUNTER BATES | — |
| GEOFF DAVIS | — |
| LAUREN O'BRIEN | — |
Health Issues HCR
Prescription drug pricing; Prescription drug importation; Support delay of CMS final rule to change Medicare reimbursement policy for biosimilars; Oppose CMMI proposed rule for Medicare Part B Drug Payment Model demo; Monitor legislative discussions on 21st Century Cures (H.R. 6) and Senate biomedical innovation bills; Monitor efforts to delay ACA branded prescription drug fee for certain products; Monitor legislative discussions regarding vial size and wasteage (S. 2956; Senate Agriculture Approps bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER HUNTER BATES | — |
| CHASE WATSON HIENEMAN New | Intern, Office of Senator Mitch McConnell |
| LAUREN O'BRIEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.